Shares of GENMAB A/S/S (OTCMKTS:GMXAY – Get Free Report) crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $20.68 and traded as high as $20.98. GENMAB A/S/S shares last traded at $20.92, with a volume of 1,872,721 shares traded.
GENMAB A/S/S Trading Up 1.8 %
The business has a fifty day simple moving average of $20.67 and a two-hundred day simple moving average of $23.13.
GENMAB A/S/S Company Profile
Genmab A/S, a biotechnology company, develops antibody therapeutics for the treatment of cancer primarily in Denmark. The company markets DARZALEX, a human IgG1k monoclonal antibody for the treatment of patients with multiple myeloma (MM); and Arzerra, a human IgG1k monoclonal antibody for the treatment of chronic lymphocytic leukemia (CLL).
Featured Articles
- Five stocks we like better than GENMAB A/S/S
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- How to Invest in Blue Chip Stocks
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- How Technical Indicators Can Help You Find Oversold Stocks
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for GENMAB A/S/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENMAB A/S/S and related companies with MarketBeat.com's FREE daily email newsletter.
